Consensus Universal Health Services, Inc.

Equities

UHS

US9139031002

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 01:30:02 10/07/2025 am IST			5-day change	1st Jan Change
182.56 ^USD	+0.17%		-3.38%	+1.75%

03/07	Universal Health Services, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08:00 AM
17/06	Leerink Partners Adjusts PT on Universal Health Services to $253 From $252, Maintains Outperform Rating	MT

Evolution of the Average Target: Universal Health Services, Inc.

Evolution of the Target Price: Universal Health Services, Inc.

Changes in Analyst Recommendations: Universal Health Services, Inc.

f8339a.pT6JA4DkTdDQNHIvzQGySKRUjFWPRMmDXp7Ol1qRkaE.4WnHQd-LO5ucRzAe_UKGD5J55DTADID2EduI9TfI9pLoUOBk0pUYoON-EQ~245511c433387e33ed80495232f0edea

Analysts' recommendations: Universal Health Services, Inc.

Leerink Partners Adjusts PT on Universal Health Services to $253 From $252, Maintains Outperform Rating	17/06	MT
Leerink Partners Adjusts Universal Health Services Price Target to $252 From $250	03/06	MT
Baird Adjusts Price Target on Universal Health Services to $243 From $224, Maintains Neutral Rating	21/05	MT
Mizuho Securities Adjusts Universal Health Services Price Target to $242 From $240	20/05	MT
Goldman Sachs Cuts Price Target on Universal Health Services to $197 From $204	03/05	MT
Deutsche Bank Adjusts Universal Health Services' Price Target to $220 From $240	30/04	MT
Guggenheim Adjusts Universal Health Services' Price Target to $212 From $208	30/04	MT
RBC Cuts Price Target on Universal Health Services to $201 From $211, Keeps Sector Perform Rating	30/04	MT
Barclays Adjusts PT on Universal Health Services to $257 From $249, Maintains Overweight Rating	29/04	MT
Baird Downgrades Universal Health Services to Neutral From Outperform, Adjusts PT to $224 From $274	15/04	MT
Guggenheim Initiates Universal Health Services at Buy With $208 Price Target	09/04	MT
Morgan Stanley Initiates Universal Health Services at Equalweight With $200 Price Target	26/03	MT
JPMorgan Cuts Price Target on Universal Health Services to $215 From $226	14/03	MT
Wells Fargo Adjusts Price Target on Universal Health Services to $225 From $230, Keeps Overweight Rating	10/03	MT
Stephens Adjusts Price Target on Universal Health Services to $223 From $210, Maintains Equalweight Rating	28/02	MT
UBS Adjusts Price Target on Universal Health Services to $280 From $267, Keeps Buy Rating	28/02	MT
Leerink Adjusts Price Target on Universal Health Services to $250 From $270, Maintains Outperform Rating	27/02	MT
Barclays Adjusts Price Target on Universal Health Services to $249 From $271, Keeps Overweight Rating	27/02	MT
Stephens Cuts Universal Health Services Price Target to $210 From $220	13/01	MT
Goldman Sachs Downgrades Universal Health Services to Neutral From Buy, Adjusts Price Target to $197 From $228	16/12	MT
TD Cowen Adjusts Price Target on Universal Health Services to $251 From $275, Maintains Buy Rating	26/11	MT
Wells Fargo Adjusts Price Target on Universal Health Services to $230 From $285, Keeps Overweight Rating	25/11	MT
Wells Fargo Adjusts Price Target on Universal Health Services to $285 From $275	06/11	MT
Goldman Sachs Adjusts Price Target on Universal Health Services to $228 From $229	30/24/30	MT
TD Cowen Adjusts Price Target on Universal Health Services to $275 From $283, Maintains Buy Rating	28/24/28	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus (Composite)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Ecart obj. / dr
	UNIVERSAL HEALTH SERVICES, INC.					+24.01%
	HCA HEALTHCARE, INC.					+3.06%
	CVS HEALTH CORPORATION					+19.11%
	FRESENIUS SE & CO. KGAA					+16.16%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+13.64%
	LABCORP HOLDINGS INC.					+7.86%
	QUEST DIAGNOSTICS INCORPORATED					+6.72%
	FRESENIUS MEDICAL CARE AG					+8.41%
	TENET HEALTHCARE CORPORATION					+8.46%
	MAX HEALTHCARE INSTITUTE LIMITED					-8.07%
	Average					+9.93%
	Weighted average by Cap.					+10.43%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

182.25USD

Average target price

226.01USD

Spread / Average Target

+24.01%

High Price Target

280.00USD

Spread / Highest target

+53.64%

Low Price Target

200.00USD

Spread / Lowest Target

+9.74%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Leerink Partners
Baird
Mizuho Securities
Goldman Sachs
Deutsche Bank Securities
Guggenheim
RBC Capital Markets
Barclays
Morgan Stanley
JPMorgan Chase
Wells Fargo Securities
Stephens Inc.
UBS
TD Cowen
KeyBanc Capital Markets
Cantor Fitzgerald
Credit Suisse
BofA Securities
Wolfe Research
SVB Securities LLC
BMO Capital
Loop Capital
SVB Leerink
Seaport Global Securities
Cowen
Citigroup